American Society for Pharmacology & Experimental Therapeutics Incorporated

Nonprofit profile at a glance

EIN
586032060
IRS 990 coverage
2010–2024
Forms available
Form 990 2024, Form 990-T 2024
Location
Rockville, MD, USA
Phone
3016347065
Rating
85
Verdict
STRONG
Rating confidence
Moderate

Official website

Reported finances

Revenue
$6,734,604
Expenses
$7,360,722
Assets
$31,116,051
Liabilities
$4,138,245

Source: IRS Form 990. Selected filing: tax year 2024. Amounts in USD.

Leadership & pay

18 people listed

Executive titles in this filing

  • MICHAEL L JARVIS (PAST PRESIDENT (UNTIL 06/30/2024))
  • NAMANDJE BUMPUS (PRESIDENT)
  • CAROL BECK (PRESIDENT ELECT)
  • RANDY HALL (COUNCILOR, THEN PRESIDENT ELECT)

Highest reported compensation

  • DAVID JACKSON (EXECUTIVE OFFICER): $338,072 total reported compensation
  • ROBERT STANLEY (CHIEF FINANCIAL OFFICER): $265,892 total reported compensation
  • CATHERINE FRY (EDUCATION DIRECTOR): $205,267 total reported compensation

Source: IRS Form 990. Selected filing: tax year 2024. Names and roles reflect this filing, not necessarily current officeholders.

Overview

Mission

The american society for pharmacology and experimental therapeutics (aspet) is a 4,000 member scientific society whose members conduct basic and clinical pharmacological research and work for academia, government, large pharmaceutical companies, small biotech companies, and non-profit organizations.

What it reported doing in 2024

Publications - the society publishes scientific and educational journals and other publications for the scientific community including the following: journal of pharmacology and experimental therapeutics - monthly research publication covering topics including the interactions of chemicals with biological systems, including autonomic, behavioral, cardiovascular, cellular, clinical, developmental, gastrointestinal, immuno-, neuro-, pulmonary and renal pharmacology, as well as analgesics, drug abuse, metabolism and disposition, chemotherapy, and toxicology.pharmacological reviews - quarterly review journal covering concentrations in pharmacology, experimental therapeutics, toxicology, and chemotherapy.molecular pharmacology - monthly publication with an emphasis on research of drug action and selective toxicity at the molecular level. Original applications of biochemistry, biophysics, genetics and molecular biology are combined with pharmacologic research to solve basic problems in pharmacology and toxicology.drug metabolism and disposition - monthly publication covering the fields of pharmacokinetics, pharmacodynamics and mechanisms, genetic nutritional or hormonal factors affecting the biological fate of chemicals, and the toxicological consequences of xenobiotic metabolism.the pharmacologist - monthly publication with the purpose of informing pharmacologists about society affairs and other matters of professional interest. Distributed electronically to aspet members and mailed to nonmember subscribers as well as members who pay for a print subscription.

Operating model

Revenue model
Earned-program. 86% of the money available for current operations came from fees and other program revenue.
Distribution model
Direct operator. The filing allocates 95% of reported program-service expenses outside its grant, affiliate-payment, and member-benefit lines. This expense classification does not rule out separately announced grant awards.

The verdict

STRONG - A large share of available resources goes toward mission work and the filed numbers largely add up. Expenses are high relative to revenue and reported officer compensation is a large share of total spending, which may reflect staffing concentration.

Rating breakdown

  • Financial Efficiency: 82
  • Transparency & Controls: 87
  • Accountability: 94
  • Sustainability: 38
  • Growth: 100

Detailed rating inputs

Financial Efficiency

  • Mission deployment rate: 100%; rating input score 100
  • Program expense ratio: 78.8%; rating input score 79
  • Fundraising efficiency: Limited

Transparency & Controls

  • Consistency checks: 100%; rating input score 100; 63rd percentile among comparable filings
  • Pay-setting controls: 4 of 6 controls in place; rating input score 67
    • Compensation committee: Missing
    • Independent consultant: Pass
    • Other Form 990s reviewed: Missing
    • Written employment contract: Pass
    • Compensation survey or study: Pass
    • Board or committee approval: Pass
  • Foreign activity oversight: Limited
  • Grant itemization coverage: 100%; rating input score 100; 72nd percentile among comparable filings
  • Major donor itemization: Yes; rating input score 100
  • Related-party transparency: Limited

Accountability

  • Independent voting board: 88.9%; rating input score 89; 20th percentile among comparable filings
  • Governance controls: 8 of 8 controls in place; rating input score 100
    • Conflict-of-interest policy: Pass
    • Whistleblower policy: Pass
    • Document-retention policy: Pass
    • CEO compensation review process: NotApplicable
    • Other executive compensation review process: Pass
    • Form 990 shared with the board: Pass
    • Board meeting minutes documented: Pass
    • Audit committee oversight: Pass
    • Independent financial-statement audit: Pass

Sustainability

  • Operating margin: -9.3%; rating input score 14; 14th percentile among comparable filings
  • Total-asset coverage ratio: 4.23; rating input score 81; 81st percentile among comparable filings
  • Liabilities to assets ratio: 0.13; rating input score 53; 53rd percentile among comparable filings
  • Officer compensation ratio: 21.6%; rating input score 11; 11th percentile among comparable filings

Growth

  • Program expense growth: 2.7% per year; rating input score 100; 26th percentile among comparable filings
  • Revenue growth: 0.5% per year; rating input score 100; 13th percentile among comparable filings
  • Asset growth: 5.1% per year; rating input score 100; 35th percentile among comparable filings

Details

  • Where the money goes: 100% of revenue deployed · 78.8% of spending went to programs
  • Governance: 8 of 9 board members independent · 8 of 8 filing controls reported
  • Programs: 7 filed program accomplishments · $5.8M in reported program spending
  • Leadership: top reported pay $338K · 18 people listed · 4 of 6 pay-setting controls reported
  • Highest-paid contractors: 5 contractors listed · $2.5M reported
  • Consistency: 36 of 36 current checks pass
  • Schedules: 6 filed schedules · includes major donors, grants, and executive pay
  • Filing history: 14 filing years from 2010 to 2024
  • Contacts: How to reach this organization
  • Money network: 14 filed money-flow records
  • Related organizations: 5 filed related-organization links
  • Grant readiness: Federal tax and exclusion status, award history, and grant-maker relationships.
  • People: Everyone the filings name, and which of them the filings identify by more than a name.

Key Signals

Signals prioritize questions for review. They are not findings of misconduct.

  • High — Sustainability: Operating margin scored 14/100.
  • High — Sustainability: Officer compensation ratio scored 11/100.
  • Review — Sustainability: Liabilities to assets ratio scored 53/100.